| J9271 | Injection, pembrolizumab, 1 mg | 12,500 | $40 | $500K |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 5,970 | $40 | $214.9K |
| J0897 | Injection, denosumab, 1 mg | 6,720 | $20 | $127.7K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 1,220 | $80 | $96.5K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 710 | $110 | $80.8K |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 11,480 | $10 | $68.9K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 300 | $140 | $42.3K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 220 | $160 | $34.7K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 280 | $80 | $21.6K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 170 | $70 | $11.1K |